KAI Stock Analysis: Kadant | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 3.136m USD | 12M Return: -9.2% | US48282T1043 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 43.1M
EPS Trend: -5.0%
Qual. Beats: 2
Rev. Trend: 90.1%
Qual. Beats: 5
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Kadant Inc. (NYSE: KAI) is a global supplier of industrial technologies and engineered systems, operating through three business segments: Flow Control, Industrial Processing, and Material Handling. The Flow Control segment provides fluid-handling systems, doctor blades, and water-filtration systems, while Industrial Processing offers equipment such as debarkers, chippers, and pulping systems, and Material Handling supplies vibratory, conveying, and baling equipment. The product portfolio indicates that a significant portion of the business serves the pulp, paper, and recycling industries, which are core end markets within the industrial machinery sector.
The company sells through a mix of direct sales, independent sales agents, and distributors, reflecting a diversified go-to-market approach typical of the Industrial Machinery & Supplies & Components sub-industry. Originally incorporated in 1991 as Thermo Fibertek, Inc., the company adopted its current name in July 2001 and is headquartered in Westford, Massachusetts.
- Pulp and paper industry capex cycle drives segment revenue
- Recyclable material demand boosts Material Handling segment growth
- Margin expansion from acquisitions and engineered product mix
| Net Income: 109.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -1.64 > 1.0 |
| NWC/Revenue: 30.96% < 20% (prev 26.84%; Δ 4.11% < -1%) |
| CFO/TA 0.10 > 3% & CFO 183.4m > Net Income 109.7m |
| Net Debt (380.5m) to EBITDA (249.9m): 1.52 < 3 |
| Current Ratio: 2.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (11.8m) vs 12m ago 0.30% < -2% |
| Gross Margin: 44.44% > 18% (prev 44.98%; Δ -0.54% > 0.5%) |
| Asset Turnover: 68.30% > 50% (prev 68.99%; Δ -0.69% > 0%) |
| Interest Coverage Ratio: 4.82 > 6 (EBIT TTM 174.6m / Interest Expense TTM 36.2m) |
| A: 0.19 (Total Current Assets 580.8m - Total Current Liabilities 224.2m) / Total Assets 1.89b |
| B: 0.53 (Retained Earnings 995.1m / Total Assets 1.89b) |
| C: 0.10 (EBIT TTM 174.6m / Avg Total Assets 1.69b) |
| D: 1.20 (Book Value of Equity 1.02b / Total Liabilities 855.5m) |
| Altman-Z'' = 4.91 = AAA |
| DSRI: 0.92 (Receivables 168.7m/163.7m, Revenue 1.15b/1.02b) |
| GMI: 1.01 (GM 44.98% / 44.44%) |
| AQI: 1.02 (AQ_t 0.57 / AQ_t-1 0.56) |
| SGI: 1.13 (Revenue 1.15b / 1.02b) |
| TATA: -0.04 (NI 109.7m - CFO 183.4m) / TA 1.89b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of September 27, 2026, the stock is trading at USD 273.89 with a total of 110,623 shares traded. Over the past week, the price has changed by +3.14%, over one month by -9.56%, over three months by -14.86% and over the past year by -9.24%.
Current recommended Stop Loss: 261.20 (which is 4.6% or 1.3 ATR below the current price).
Kadant has received a consensus analysts rating of 3.75. Therefore, it is recommended to hold KAI.
- StrongBuy: 1
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 361.7 | 32% |
P/E Trailing = 28.7403
P/E Forward = 19.3424
P/S = 2.7219
P/B = 3.0837
P/EG = 3.2291
Revenue TTM = 1.15b USD
EBIT TTM = 174.6m USD
EBITDA TTM = 249.9m USD
Long Term Debt = 507.5m USD (from longTermDebt, last quarter)
Short Term Debt = 3.18m USD (from shortTermDebt, last quarter)
Debt = 515.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 4.39m
Net Debt = 380.5m USD (calculated: Debt 515.0m - CCE 134.5m)
Enterprise Value = 3.52b USD (3.14b + Debt 515.0m - CCE 134.5m)
Interest Coverage Ratio = 4.82 (Ebit TTM 174.6m / Interest Expense TTM 36.2m)
EV/FCF = 21.98x (Enterprise Value 3.52b / FCF TTM 160.0m)
FCF Yield = 4.55% (FCF TTM 160.0m / Enterprise Value 3.52b)
FCF Margin = 13.89% (FCF TTM 160.0m / Revenue TTM 1.15b)
Net Margin = 9.52% (Net Income TTM 109.7m / Revenue TTM 1.15b)
Gross Margin = 44.44% ((Revenue TTM 1.15b - Cost of Revenue TTM 640.1m) / Revenue TTM)
Gross Margin QoQ = 43.79% (prev 45.01%)
Tobins Q-Ratio = 1.86 (Enterprise Value 3.52b / Total Assets 1.89b)
Interest Expense / Debt = 7.03% (Interest Expense 36.2m / Debt 515.0m)
Taxrate = 29.06% (45.6m / 156.9m)
NOPAT = 123.9m (EBIT 174.6m * (1 - 29.06%))
Current Ratio = 2.59 (Total Current Assets 580.8m / Total Current Liabilities 224.2m)
Debt / Equity = 0.50 (Debt 515.0m / totalStockholderEquity, last quarter 1.02b)
Debt / EBITDA = 1.52 (Net Debt 380.5m / EBITDA 249.9m)
Debt / FCF = 2.38 (Net Debt 380.5m / FCF TTM 160.0m)
Total Stockholder Equity = 987.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.50% (Net Income 109.7m / Total Assets 1.89b)
RoE = 11.12% (Net Income TTM 109.7m / Total Stockholder Equity 987.1m)
RoCE = 11.68% (EBIT 174.6m / Capital Employed (Equity 987.1m + L.T.Debt 507.5m))
RoIC = 7.69% (NOPAT 123.9m / Invested Capital 1.61b)
WACC = 11.23% (E(3.14b)/V(3.65b) * Re(12.25%) + D(515.0m)/V(3.65b) * Rd(7.03%) * (1-Tc(0.29)))
Discount Rate = 12.25% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 90.21 | Cagr: 0.28%
[DCF] Terminal Value 67.09% ; FCFF base≈156.0m ; Y1≈165.2m ; Y5≈194.6m
[DCF] Fair Price = 137.3 (EV 2.00b - Net Debt 380.5m = Equity 1.62b / Shares 11.8m; r=11.23% [WACC]; 5y FCF grow 6.57% → 2.50% )
EPS Correlation: -4.97 | EPS CAGR: -0.28% | SUE: 2.60 | # QB: 2
Revenue Correlation: 90.05 | Revenue CAGR: 5.58% | SUE: 2.83 | # QB: 5
EPS current Quarter (2026-09-30): EPS=2.93 | Chg30d=-7.79% | Revisions=-57% | Analysts=4
EPS current Year (2026-12-31): EPS=12.04 | Chg30d=-3.56% | Revisions=+29% | GrowthEPS=+30.0% | GrowthRev=+13.9%
EPS next Year (2027-12-31): EPS=13.51 | Chg30d=-4.47% | Revisions=-29% | GrowthEPS=+12.2% | GrowthRev=+5.8%
[Analyst] Revisions Ratio: -27% (up=4, down=8)